With the analysis among 648 patents, we discovered top 152 key players by total patent application. Bayer Pharma AG, Bayer AG, Ionis Pharmaceuticals, Inc. are dominant in this area. They take 21.30% of the total patent filing.
Berlin, Germany
Patent: 50
Nordrhein-Westfalen, Germany
Patent: 44
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 44
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 36
New York, United States
Patent: 35
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Guangdong Sheng, China
Patent: 22
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 18
Maharashtra, India
Patent: 18
New Jersey, United States
Patent: 15
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 15
With the analysis among 11 patents, we discovered top 4 start-ups by total patent application. KLUS Pharma, Inc., Institut National de la Santé et de la Recherche Médicale, Imperative Care, Inc. are active in this area.
New Jersey, United States
Patent: 5
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 2
Anthos Therapeutics, Inc.
Massachusetts, United States
Patent: 1
With the analysis among related 309 patents applied in the last 5 years. We discover 88 most active companies in this area. The fast-growing Bayer AG, Ionis Pharmaceuticals, Inc., Bayer Pharma AG take 29.13% of patent filing during this period.
Nordrhein-Westfalen, Germany
Patent: 35
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 31
Berlin, Germany
Patent: 24
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Guangdong Sheng, China
Patent: 22
Luxembourg, Belgium
Patent: 11
Oost-Vlaanderen, Belgium
Patent: 9
Antwerpen, Belgium
Patent: 9
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Sichuan Sheng, China
Patent: 9
The Board of Regents of The University of Texas System
Texas, United States
Patent: 9
New York, United States
Patent: 8
With the analysis among related 309 patents in last 5 years, we discover 66 new entrants. Shenzhen Salubris Pharmaceuticals Co., Ltd., Estetra SPRL, Ablynx NV are the most active new entrants in this area.
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Guangdong Sheng, China
Patent: 22
Luxembourg, Belgium
Patent: 11
Oost-Vlaanderen, Belgium
Patent: 9
Antwerpen, Belgium
Patent: 9
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Sichuan Sheng, China
Patent: 9
Beijing Tuojie Biomedical Technology Co., Ltd.
Beijing Shi, China
Patent: 7
Nanjing Mingde New Drug Research and Development Co., Ltd.
Jiangsu Sheng, China
Patent: 7
New Jersey, United States
Patent: 5
The Heart Research Institute Ltd.
New South Wales, Australia
Patent: 4
Grifols Shared Services North America, Inc.
California, United States
Patent: 4
With the analysis among 77 patents, we discovered top 26 universities and scientific research institutions by total patent application. Universidad Autonóma Metropolitana, The University of Sydney, The Scripps Research Institute are dominant in this area. They take 31.17% of the total patent filing.
Universidad Autonóma Metropolitana
Distrito Federal, Mexico
Patent: 7
The Scripps Research Institute
California, United States
Patent: 3
Katholieke Universiteit Leuven
Vlaams-Brabant, Belgium
Patent: 2
Hamamatsu University School of Medicine
Shizuoka-ken, Japan
Patent: 2
Université de Caen Basse-Normandie
New Mexico, France
Patent: 2
California, United States
Patent: 1
The Johns Hopkins University
The University of Queensland
Queensland, Australia
Patent: 1